5th Floor, Brigade Towers,
Financial District, Gachibowli,
Hyderabad - 500032,
The market is segmented by Technique (Immunochemistry, POC Diagnostics, Molecular Diagnostics, Hematology, Tissue Diagnostics, Microbiology, Self-blood Glucose Monitoring, and Other Techniques), Product, Usability, Application, and End User
Fastest Growing Market:
The major factors that are driving the growth of the Indian in-vitro diagnostics market are the high prevalence of chronic diseases, increasing use of point-of-care (POC) diagnostics, and rising awareness and acceptance of personalized medicine and companion diagnostics.
Emerging technological innovations in healthcare, such as bio-sensors, lab-on-a-chip, wearable devices, and POC diagnostics, are increasingly becoming an important part of the healthcare landscape. POC testing helps bring testing closer to the patients and obtain results quickly for the healthcare provider to expedite diagnoses and subsequent treatment. POC diagnostic tests include whole blood glucose testing, pregnancy test, and tests for coagulation prothrombin time and international normalized ratio, D-dimer, troponin, CK-MB, hepatitis C, urine for urinalysis or drug abuse, and fecal occult blood. POC diagnostics, no longer limited to simple tests, can now be used for diagnosing serious conditions. For example, the POC test for prostate-specific antigen (PSA) is used for the diagnosis of prostate cancer in men. Similarly, several POC diagnostic products have been developed to be used on a patient’s bedside in hospitals, to get instant results without the need of sending the samples to the lab.
Thus, owing to their ease of use, ease of procurement, and ability to provide instant results, the use of POC diagnostics is rapidly increasing in India, and this, in turn, is promoting the growth of the IVD market in the country. Thus, POC technologies are an influential driver for the market studied.
As per the scope of the report, The Indian in vitro diagnostics market is inclusive of all medical devices and consumables that are utilized to perform in vitro tests on various biological samples, used for the diagnosis of various medical conditions, such as chronic diseases. The market is segmented by technique, product, usability, application, and end user.
|By Test Type|
|Disposable IVD Devices|
|Reusable IVD Devices|
|By End User|
|Hospitals & Clinics|
|Other End Users|
Report scope can be customized per your requirements. Click here.
Molecular diagnostic devices are used to analyze biological markers in the genome and proteome to detect pathogens or mutations. On the basis of technology used, molecular diagnostic devices can be segmented into chips and microarrays, mass spectroscopy, next-generation sequencing (NGS), polymerase chain reaction (PCR)-based methods, cytogenetics, and molecular imaging.
Factors, such as large outbreaks of bacterial and viral epidemics in the India, increasing demand for point-of-care diagnostics, and rapidly evolving technology, are driving the growth of the molecular diagnostics segment.
To understand key trends, Download Sample Report
The market studied is consolidated with the presence of a few major players. For the new entrants in the market, the barriers are high in this industry, and hence, few major market players hold the maximum market share. Some of the market players are Abbott Laboratories, Becton, Dickinson and Company, BioMérieux, Bio-Rad Laboratories Inc., Danaher Corporation, F. Hoffmann-La Roche AG, Qiagen NV, and Thermo Fisher Scientific.
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 High Prevalence of Chronic Diseases
4.2.2 Increasing Use of Point-of-care (POC) Diagnostics
4.2.3 Rising Awareness and Acceptance of Personalized Medicine and Companion Diagnostics
4.3 Market Restraints
4.3.1 Stringent Regulations
4.3.2 Cumbersome Reimbursement Procedures
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
5.1 By Test Type
5.1.1 Clinical Chemistry
5.1.2 Molecular Diagnostics
5.1.4 Immuno Diagnostics
5.1.5 Other Types
5.2 By Product
5.2.3 Other Products
5.3 By Usability
5.3.1 Disposable IVD Devices
5.3.2 Reusable IVD Devices
5.4 By Application
5.4.1 Infectious Disease
5.4.5 Autoimmune Disease
5.4.7 Other Applications
5.5 By End User
5.5.1 Diagnostic Laboratories
5.5.2 Hospitals & Clinics
5.5.3 Other End Users
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.2 Arkray Inc.
6.1.3 Becton, Dickinson and Company
6.1.4 bioMérieux SA
6.1.5 Bio-Rad Laboratories Inc.
6.1.6 Danaher Corporation
6.1.7 F. Hoffmann-La Roche AG
6.1.9 Sysmex Corporation
6.1.10 Thermo Fisher Scientific
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments